Academic Journal
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)
| العنوان: | A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407) |
|---|---|
| المؤلفون: | Ozaka, Masato, Nakachi, Kohei, Kobayashi, Satoshi, Ohba, Akihiro, Imaoka, Hiroshi, Terashima, Takeshi, Ishii, Hiroshi, Mizusawa, Junki, Katayama, Hiroshi, Kataoka, Tomoko, Okusaka, Takuji, Ikeda, Masafumi, Sasahira, Naoki, Miwa, Haruo, Mizukoshi, Eishiro, Okano, Naohiro, Mizuno, Nobumasa, Yamamoto, Tomohisa, Komatsu, Yoshito, Todaka, Akiko, Kamata, Ken, Furukawa, Masayuki, Fujimori, Nao, Katanuma, Akio, Takayama, Yukiko, Tsumura, Hidetaka, Fukuda, Haruhiko, Ueno, Makoto, Furuse, Junji |
| المساهمون: | Japan Agency for Medical Research and Development, National Cancer Center Japan, Ministry of Health, Labour and Welfare, National Cancer Center |
| المصدر: | European Journal of Cancer ; volume 181, page 135-144 ; ISSN 0959-8049 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ejca.2022.12.014 |
| الاتاحة: | http://dx.doi.org/10.1016/j.ejca.2022.12.014 https://api.elsevier.com/content/article/PII:S0959804922018160?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0959804922018160?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.7C0773DD |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ejca.2022.12.014 |
|---|